David Hawkins

4.1k total citations
81 papers, 2.6k citations indexed

About

David Hawkins is a scholar working on Cardiology and Cardiovascular Medicine, Aerospace Engineering and Internal Medicine. According to data from OpenAlex, David Hawkins has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 16 papers in Aerospace Engineering and 14 papers in Internal Medicine. Recurrent topics in David Hawkins's work include Venous Thromboembolism Diagnosis and Management (14 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Advanced SAR Imaging Techniques (9 papers). David Hawkins is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (14 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Advanced SAR Imaging Techniques (9 papers). David Hawkins collaborates with scholars based in United States, New Zealand and Canada. David Hawkins's co-authors include Charles G. Cochrane, Richard S. Farr, R. Neal Pinckard, P.T. Gough, Bing Ren, Yan Li, Narkunaraja Shanmugam, Miao Feng, Jiing-Kuan Yee and Rama Natarajan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David Hawkins

81 papers receiving 2.4k citations

Peers

Countries citing papers authored by David Hawkins

Since Specialization

Citations

This map shows the geographic impact of David Hawkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hawkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hawkins more than expected).

Fields of papers citing papers by David Hawkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hawkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hawkins. The network helps show where David Hawkins may publish in the future.

Co-authorship network of co-authors of David Hawkins

This figure shows the co-authorship network connecting the top 25 collaborators of David Hawkins. A scholar is included among the top collaborators of David Hawkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hawkins. David Hawkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The complex role of Rcor2: Regulates mesenchymal stromal cell differentiation in vitro but is dispensable in vivo 2024 ·Bone ·(unknown), Kati Tarkkonen, (unknown), (unknown), Vappu Nieminen-Pihala, Cristina Valensisi, (unknown), David Hawkins, Terhi J. Heino, Kaisa K. Ivaska, (unknown)	2
2	Radar Technologies for Earth Remote Sensing From CubeSat Platforms 2018 ·Proceedings of the IEEE ·Eva Peral, E. Im, Lauren Wye, Simon Lee, Simone Tanelli, Yahya Rahmat‐Samii, Stephen Horst, (unknown), Sang‐Ho Yun, (unknown), David Hawkins	74
3	Cosmology Independent Measurement of the Gas Mass Fraction Using Chandra X-ray and Sunyaev-Zel'dovich Effect Measurements of High Redshift Clusters 2009 ·Nicole Hasler, Esra Bülbül, (unknown), Marshall Joy, J. E. Carlstrom, T. Culverhouse, David Hawkins, Ryan Hennessy, James W. Lamb, E. M. Leitch, Daniel P. Marrone, Amber Miller, Tony Mroczkowski, Stephen Muchovej, Clem Pryke, Matthew K. Sharp, D. P. Woody	1
4	Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes 2008 ·Journal of Biological Chemistry ·Yan Li, Marpadga A. Reddy, Miao Feng, Narkunaraja Shanmugam, Jiing-Kuan Yee, David Hawkins, Bing Ren, Rama Natarajan	291
5	CARMA Correlator: Reconfiguration and Signal Processing 2006 ·ASPC ·K. P. Rauch, David Hawkins, (unknown)	2
6	Minimising the risk of heparin-induced osteoporosis during pregnancy 2005 ·Expert Opinion on Drug Safety ·David Hawkins, Jeffrey Evans	23
7	The Sunyaev-Zel'dovich Array 2005 ·American Astronomical Society Meeting Abstracts ·(unknown), J. E. Carlstrom, J. K. Cartwright, (unknown), David Hawkins, Ryan Hennessy, (unknown), James W. Lamb, E. M. Leitch, A. Miller, Tony Mroczkowski, Stephen Muchovej, C. Pryke, (unknown), G. Richardson, M. C. Runyan, Matthew K. Sharp, D. P. Woody	1
8	The Role of Oral Direct Thrombin Inhibitors in the Prophylaxis of Venous Thromboembolism 2004 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·David Hawkins	5
9	Atherothrombosis: Epidemiology, Pathophysiology, and Prevention 2004 ·Journal of the American Pharmacists Association ·Mark A. Munger, David Hawkins	58
10	Pharmacoeconomics of Thrombosis Management 2004 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·David Hawkins	21
11	National Pharmacy Cardiovascular Council Treatment Guidelines for the Management of Type 2 Diabetes Mellitus: Toward Better Patient Outcomes and New Roles for Pharmacists 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·David Hawkins, J. Chris Bradberry, Mark J. Cziraky, Robert L. Talbert, David W. Bartels, (unknown)	28
12	Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors 2002 ·Cardiovascular Drug Reviews ·Kenneth A. Bauer, David Hawkins, Paul C. Peters, Maurice Petitou, Jean‐Marc Herbert, C. A. A. VAN BOECKEL, Dirk G. Meuleman	122
13	Cost Effectiveness of Outpatient Anticoagulant Prophylaxis After Total Hip Arthroplasty 2000 ·Orthopedics ·William E. Wade, David Hawkins	9
14	Prevention of Venous Thromboembolism 2000 ·Archives of Internal Medicine ·(unknown), (unknown), Henry I. Bussey, Joseph A. Caprini, Anthony J. Comerota, Stuart T. Haines, David Hawkins, Mary Beth O’Connell, Richard C. Smith, Kathleen A. Stringer	149
15	Risky recycling: that "disposable" catheter may have been used before. 1999 ·PubMed ·David Hawkins	6
16	A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery 1998 ·Clinical Therapeutics ·David Hawkins, Paul C. Langley, Kem P. Krueger	29
17	The Expanding Role of Pharmacy and Therapeutics Committees 1996 ·PharmacoEconomics ·(unknown), William J. Spruill, A. Thomas Taylor, (unknown), David Hawkins	16
18	A Comparative Trial of Digoxin and Digitoxin in the Treatment of Congestive Heart Failure 1988 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Henry I. Bussey, David Hawkins, (unknown), Richard A. Walsh	12
19	Rating industrial bonds 1983 ·David Hawkins, (unknown), (unknown)	10
20	STUDIES ON CIRCULATING IMMUNE COMPLEXES 1968 ·The Journal of Experimental Medicine ·Charles G. Cochrane, David Hawkins	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact